Selected article for: "small molecule and therapeutic development"

Author: Amrita Roy; Liangzhong Lim; Shagun Srivastava; Jianxing Song
Title: Unique properties of Zika NS2B-NS3pro complexes as decoded by experiments and MD simulations
  • Document date: 2016_9_28
  • ID: l82aakrk_47
    Snippet: Our study also reveals that a small molecule previously established as an active site inhibitor is able to inhibit both linked and unlinked Zika NS2B-NS3pro complexes at high affinity. Most importantly, this molecule acts as an allosteric inhibitor for both Zika NS2B-NS3pro complexes, fundamentally different from a recently reported peptidomimetic boronic acid inhibitor which is a competitive inhibitor (25) . This suggests that Zika NS2B-NS3pro i.....
    Document: Our study also reveals that a small molecule previously established as an active site inhibitor is able to inhibit both linked and unlinked Zika NS2B-NS3pro complexes at high affinity. Most importantly, this molecule acts as an allosteric inhibitor for both Zika NS2B-NS3pro complexes, fundamentally different from a recently reported peptidomimetic boronic acid inhibitor which is a competitive inhibitor (25) . This suggests that Zika NS2B-NS3pro is susceptible to allosteric inhibition. Furthermore, as this allosteric inhibitor also has a structure scaffold very different from the peptidomimetic boronic acid inhibitor, our discovery might open up a new avenue for the future development of allosteric inhibitors, which is highly demanded to achieve therapeutic inhibition of flaviviral NS2B-NS3pro complexes (35) .

    Search related documents:
    Co phrase search for related documents
    • future development and new avenue: 1, 2, 3
    • future development and new avenue open: 1
    • high affinity and new avenue: 1, 2
    • high affinity and recently report: 1, 2
    • high affinity and site inhibitor: 1, 2, 3
    • high affinity and small molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • high affinity and therapeutic inhibition: 1
    • new avenue and peptidomimetic boronic acid: 1
    • new avenue and peptidomimetic boronic acid inhibitor: 1
    • new avenue and recently report: 1
    • new avenue and small molecule: 1, 2, 3
    • new avenue and therapeutic inhibition: 1
    • new avenue open and peptidomimetic boronic acid: 1
    • new avenue open and peptidomimetic boronic acid inhibitor: 1
    • new avenue open and therapeutic inhibition: 1
    • peptidomimetic boronic acid and therapeutic inhibition: 1
    • peptidomimetic boronic acid inhibitor and therapeutic inhibition: 1
    • site inhibitor and small molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • small molecule and therapeutic inhibition: 1, 2, 3, 4, 5, 6, 7